On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study

被引:2
|
作者
Wechsler, Michael E. [1 ]
Brusselle, Guy [2 ]
Virchow, J. Christian [3 ,4 ]
Heaney, Liam G. [5 ]
Hunter, Gillian [6 ]
Ponnarambil, Sandhia [7 ]
Martin, Neil [8 ,9 ]
Llanos, Jean-Pierre [10 ]
Porsbjerg, Celeste [11 ,12 ]
Brightling, Christopher E. [13 ]
机构
[1] Natl Jewish Hlth, Denver, CO USA
[2] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
[3] Univ Rostock, Dept Pneumol, Rostock, Germany
[4] Univ Rostock, Dept Intens Care Med, Rostock, Germany
[5] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[6] AstraZeneca, Late Stage Dev Resp & Immunol, Biometr, BioPharmaceut R&D, Cambridge, England
[7] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England
[8] AstraZeneca, Resp & Immunol, Biopharmaceut Med, Cambridge, England
[9] Univ Leicester, Leicester, Leics, England
[10] Global Med Affairs, Thousand Oaks, CA USA
[11] Univ Copenhagen, Dept Resp Med, Bispebjerg Hosp, Copenhagen, Denmark
[12] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
[13] Univ Leicester, Inst Lung Hlth, Natl Inst Hlth & Care Res, Leicester Biomed Res Ctr, Leicester, Leics, England
关键词
Asthma; -; management;
D O I
10.1183/13993003.congress-2023.PA4722
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] ON-TREATMENT CLINICAL REMISSION WITH TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 DESTINATION STUDY
    Wechsler, M. E.
    Brusselle, G.
    Virchow, J. C.
    Heaney, L. G.
    Hunter, G.
    Ponnarambil, S.
    Martin, N.
    Llanos, J-P
    Porsbjerg, C.
    Brightling, C. E.
    THORAX, 2023, 78 (SUPPL_4) : A272 - A273
  • [2] On-treatment clinical remission with tezepelumab among patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study
    Castro, M.
    Ambrose, C. S.
    Colice, G.
    Roseti, S. L.
    Kmita, K.
    Cook, B.
    Martin, N.
    Llanos-Ackert, J.
    Menzies-Gow, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies
    Wechsler, Michael E.
    Brusselle, Guy
    Virchow, J. Christian
    Bourdin, Arnaud
    Kostikas, Konstantinos
    Llanos, Jean-Pierre
    Roseti, Stephanie L.
    Ambrose, Christopher S.
    Hunter, Gillian
    Jackson, David J.
    Castro, Mario
    Lugogo, Njira
    Pavord, Ian D.
    Martin, Neil
    Brightling, Christopher E.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64 (06)
  • [4] Clinical Responses to Treatment with Tezepelumab Among Patients with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Lugogo, N. L.
    Ambrose, C. S.
    Colice, G.
    Kmita, K.
    Cook, B.
    Ponnarambil, S.
    Ackert, J. Llanos
    Menzies-Gow, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Tezepelumab in the Treatment of Uncontrolled Severe Asthma
    Feist, Jacqueline
    Lipari, Melissa
    Kale-Pradhan, Pramodini
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (01) : 62 - 70
  • [6] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Ambrose, Christopher S.
    Colice, Gene
    Hunter, Gillian
    Cook, Bill
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Israel, Elliot
    ADVANCES IN THERAPY, 2023, 40 (11) : 4957 - 4971
  • [7] EFFECT OF TEZEPELUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 NAVIGATOR STUDY
    Israel, Elliot
    Menzies-Gow, Andrew
    Colice, Gene
    Ambrose, Christopher
    Hunter, Gillian
    Cook, William
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    CHEST, 2021, 160 (04) : 41A - 43A
  • [8] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Andrew Menzies-Gow
    Christopher S. Ambrose
    Gene Colice
    Gillian Hunter
    Bill Cook
    Nestor A. Molfino
    Jean-Pierre Llanos
    Elliot Israel
    Advances in Therapy, 2023, 40 : 4957 - 4971
  • [9] Tezepelumab Treatment Reduced Asthma Symptomatic Days in Adults and Adolescents with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Carr, Warner
    Jain, Neal
    Ambrose, Chris
    Clarke, Nicole
    Martin, Neil
    Kmita, Kamil
    Desai, Pooja
    Llanos-Ackert, Jean-Pierre
    Ponnarambil, Sandhia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB16 - AB16
  • [10] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207